Ashton Thomas Securities’s Amedisys AMED Stock Holding History

Ashton Thomas Securities’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$193	–	298
2024 Q3	$193	Buy	+2	New	+$195	﹤0.01%	1229

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Ashton Thomas Securities's AMED Position: Q4 2024 in Review

Ashton Thomas Securities sold out of Amedisys (AMED) in Q4 2024, closing a stake of 2 shares — an estimated $193 sold.

Ashton Thomas Securities first reported a position in AMED in Q3 2024 and held it in 1 quarter. The position peaked at $193 in Q3 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

Ashton Thomas Securities reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
Ashton Thomas Securities sold 2 Amedisys shares in Q4 2024, an estimated $193.
Ashton Thomas Securities first reported a position in Amedisys in Q3 2024 and held it in 1 quarter.
Ashton Thomas Securities's Amedisys position peaked at $193 in Q3 2024.
290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Ashton Thomas Securities's 13F filing for Q4 2024, filed 11 Feb 2025.